FOX04
This peptide has been utilized in preclinical studies examining FOXO4-p53 binding dynamics, apoptotic pathway signaling in senescent cell models, DNA damage response mechanisms, and cellular senescence regulatory pathways — independent of the broader transcriptional effects associated with endogenous FOXO4 activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amount: 10 mg per vial
- Purity:≥ 98% (HPLC tested)
- Sequence: FOXO4-DRI fragment
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.




